Cargando…

Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension

BACKGROUND: Recently, we and others have reported a causal role for oxidized lipids in the pathogenesis of pulmonary hypertension (PH). However, the role of low‐density lipoprotein receptor (LDL‐R) in PH is not known. METHODS AND RESULTS: We examined the role of LDL‐R in the development of PH and de...

Descripción completa

Detalles Bibliográficos
Autores principales: Umar, Soban, Ruffenach, Gregoire, Moazeni, Shayan, Vaillancourt, Mylene, Hong, Jason, Cunningham, Christine, Cao, Nancy, Navab, Sara, Sarji, Shervin, Li, Min, Lee, Lisa, Fishbein, Greg, Ardehali, Abbas, Navab, Mohamad, Reddy, Srinivasa T., Eghbali, Mansoureh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033825/
https://www.ncbi.nlm.nih.gov/pubmed/31914876
http://dx.doi.org/10.1161/JAHA.119.012063
_version_ 1783499748485890048
author Umar, Soban
Ruffenach, Gregoire
Moazeni, Shayan
Vaillancourt, Mylene
Hong, Jason
Cunningham, Christine
Cao, Nancy
Navab, Sara
Sarji, Shervin
Li, Min
Lee, Lisa
Fishbein, Greg
Ardehali, Abbas
Navab, Mohamad
Reddy, Srinivasa T.
Eghbali, Mansoureh
author_facet Umar, Soban
Ruffenach, Gregoire
Moazeni, Shayan
Vaillancourt, Mylene
Hong, Jason
Cunningham, Christine
Cao, Nancy
Navab, Sara
Sarji, Shervin
Li, Min
Lee, Lisa
Fishbein, Greg
Ardehali, Abbas
Navab, Mohamad
Reddy, Srinivasa T.
Eghbali, Mansoureh
author_sort Umar, Soban
collection PubMed
description BACKGROUND: Recently, we and others have reported a causal role for oxidized lipids in the pathogenesis of pulmonary hypertension (PH). However, the role of low‐density lipoprotein receptor (LDL‐R) in PH is not known. METHODS AND RESULTS: We examined the role of LDL‐R in the development of PH and determined the efficacy of high‐density lipoprotein mimetic peptide 4F in mitigating PH. Explanted human lungs and plasma from patients with PH and control subjects were analyzed for gene expression, histological characteristics, and lipoprotein oxidation. Male LDL‐R null (LDL‐R knockout) mice (12–15 months old) were fed chow, Western diet (WD), WD with 4F, and WD with scramble peptide for 12 weeks. Serial echocardiography, cardiac catheterization, oxidized LDL assay, real‐time quantitative reverse transcription–polymerase chain reaction, and histological analysis were performed. The effect of LDL‐R knockdown and oxidized LDL on human pulmonary artery smooth muscle cell proliferation was assessed in vitro. LDL‐R and CD36 expression levels were significantly downregulated in the lungs of patients with PH. Patients with PH also had increased lung lipid deposits, oxidized LDL, E06 immunoreactivity, and plasma oxidized LDL/LDL ratio. LDL‐R knockout mice on WD developed PH, right ventricular hypertrophy, right ventricular dysfunction, pulmonary vascular remodeling, fibrosis, and lipid deposition in lungs, aortic atherosclerosis, and left ventricular dysfunction, which were prevented by 4F. Interestingly, PH in WD group preceded left ventricular dysfunction. Oxidized LDL or LDL‐R knockdown significantly increased proliferation of human pulmonary artery smooth muscle cells in vitro. CONCLUSIONS: Human PH is associated with decreased LDL‐R in lungs and increased oxidized LDL in lungs and plasma. WD‐fed LDL‐R knockout mice develop PH and right ventricular dysfunction, implicating a role for LDL‐R and oxidized lipids in PH.
format Online
Article
Text
id pubmed-7033825
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70338252020-02-27 Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension Umar, Soban Ruffenach, Gregoire Moazeni, Shayan Vaillancourt, Mylene Hong, Jason Cunningham, Christine Cao, Nancy Navab, Sara Sarji, Shervin Li, Min Lee, Lisa Fishbein, Greg Ardehali, Abbas Navab, Mohamad Reddy, Srinivasa T. Eghbali, Mansoureh J Am Heart Assoc Original Research BACKGROUND: Recently, we and others have reported a causal role for oxidized lipids in the pathogenesis of pulmonary hypertension (PH). However, the role of low‐density lipoprotein receptor (LDL‐R) in PH is not known. METHODS AND RESULTS: We examined the role of LDL‐R in the development of PH and determined the efficacy of high‐density lipoprotein mimetic peptide 4F in mitigating PH. Explanted human lungs and plasma from patients with PH and control subjects were analyzed for gene expression, histological characteristics, and lipoprotein oxidation. Male LDL‐R null (LDL‐R knockout) mice (12–15 months old) were fed chow, Western diet (WD), WD with 4F, and WD with scramble peptide for 12 weeks. Serial echocardiography, cardiac catheterization, oxidized LDL assay, real‐time quantitative reverse transcription–polymerase chain reaction, and histological analysis were performed. The effect of LDL‐R knockdown and oxidized LDL on human pulmonary artery smooth muscle cell proliferation was assessed in vitro. LDL‐R and CD36 expression levels were significantly downregulated in the lungs of patients with PH. Patients with PH also had increased lung lipid deposits, oxidized LDL, E06 immunoreactivity, and plasma oxidized LDL/LDL ratio. LDL‐R knockout mice on WD developed PH, right ventricular hypertrophy, right ventricular dysfunction, pulmonary vascular remodeling, fibrosis, and lipid deposition in lungs, aortic atherosclerosis, and left ventricular dysfunction, which were prevented by 4F. Interestingly, PH in WD group preceded left ventricular dysfunction. Oxidized LDL or LDL‐R knockdown significantly increased proliferation of human pulmonary artery smooth muscle cells in vitro. CONCLUSIONS: Human PH is associated with decreased LDL‐R in lungs and increased oxidized LDL in lungs and plasma. WD‐fed LDL‐R knockout mice develop PH and right ventricular dysfunction, implicating a role for LDL‐R and oxidized lipids in PH. John Wiley and Sons Inc. 2020-01-09 /pmc/articles/PMC7033825/ /pubmed/31914876 http://dx.doi.org/10.1161/JAHA.119.012063 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Umar, Soban
Ruffenach, Gregoire
Moazeni, Shayan
Vaillancourt, Mylene
Hong, Jason
Cunningham, Christine
Cao, Nancy
Navab, Sara
Sarji, Shervin
Li, Min
Lee, Lisa
Fishbein, Greg
Ardehali, Abbas
Navab, Mohamad
Reddy, Srinivasa T.
Eghbali, Mansoureh
Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension
title Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension
title_full Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension
title_fullStr Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension
title_full_unstemmed Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension
title_short Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension
title_sort involvement of low‐density lipoprotein receptor in the pathogenesis of pulmonary hypertension
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033825/
https://www.ncbi.nlm.nih.gov/pubmed/31914876
http://dx.doi.org/10.1161/JAHA.119.012063
work_keys_str_mv AT umarsoban involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension
AT ruffenachgregoire involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension
AT moazenishayan involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension
AT vaillancourtmylene involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension
AT hongjason involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension
AT cunninghamchristine involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension
AT caonancy involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension
AT navabsara involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension
AT sarjishervin involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension
AT limin involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension
AT leelisa involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension
AT fishbeingreg involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension
AT ardehaliabbas involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension
AT navabmohamad involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension
AT reddysrinivasat involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension
AT eghbalimansoureh involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension